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A better understanding of the combined impact of different space stressors on
human health is urgently warranted, considering the upcoming long-duration missions
beyond lower Earth orbit. Therefore, a growing number of particle accelerator facilities
implement ground-based set-ups to study the effect of simulated space radiation
with simulated psychological or physical stressors. The immune system is highly
sensitive to these types of stressors and limited information is currently available on
the impact of the complex space radiation environment on the astronauts’ immune
function. This pilot study presents a first step in the implementation of a ground-based
set-up with neutron irradiation, which is considered to be an important secondary
component in space radiation fields. The effect of dose rate on immune alterations
was studied using the in vitro cytokine release assay. Whole blood samples (n = 8)
were exposed to 0.125 or 1Gy of neutron irradiation (fluence-weighted average
energy: 29.8 MeV) at a lower dose rate (LDR) of 0.015 Gy/min and a higher
dose rate (HDR) of 0.400 Gy/min. Immediately post-irradiation, blood samples were
stimulated with lipopolysaccharide (LPS), heat-killed Listeria monocytogenes (HKLM)
or lectin pokeweed mitogen (PWM), and incubated for 24 h. Cell-mediated immunity
was examined by analysing interleukin-2 (IL-2), interferon-gamma (IFN-γ), tumour
necrosis factor-alpha (TNF-α), and interleukin-10 (IL-10) plasma levels. Stimulants
significantly increased all cytokine levels except IL-2, where only PWM induced a
significant increase. In general, no statistically significant changes were observed in
IL-2, IFN-γ, and TNF-α concentrations at different neutron doses and dose rates
when compared to their stimulated, sham-irradiated controls. After PWM-stimulation,
IL-10 levels were significantly increased at 0.125Gy HDR and 1Gy LDR. In a pooled
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analysis, the HDR significantly increased IL-2 titres (under PWM-stimulation) and IFN-γ
titres (with all stimulants), but significantly decreased TNF-α secretion in unstimulated
cultures. Due to the limited sample number, no strong conclusions could be made in this
pilot study on the effect of neutron radiation as a single stressor on cytokine secretion
in response to different stimuli. However, some interesting trends and dose rate effects
were observed, which pave the way for future investigations on the synergistic effects of
multiple space stressors on immune cell function.
Keywords: radiation in space, immune system, space radiobiology, terrestrial analog, cytokine release assay in
vitro, dose rate effect, astronaut health, neutron radiation
INTRODUCTION
Space travel comprises a unique and complex stress model
composed of both physical (cosmic radiation and microgravity)
and psychological stress factors, known to induce a large
variety of systemic physiological effects that are proven to
be detrimental to astronaut’s health [1–3]. Of the observed
outcomes, a dysfunctional immune system remains a major
concern for future manned exploration beyond lower Earth orbit
(LEO) or toMars [4]. Recent studies confirm that immunological
changes are an in-flight phenomenon, observed throughout
short-duration Space Shuttle missions or a long-duration stay on
the International Space Station (ISS) [5–8]. During interplanetary
missions, crewmembers will spend an unprecedented amount
of time in space, where the synergy of the elevated radiation
exposure coupled with persisting immune alterations could
potentially increase the cancer incidence, jeopardising astronaut’s
health and mission success [7, 9–12]. For this reason, the
potential impact of space radiation on the dysregulation of
normal immune function will be the focus of this pilot study
[13, 14].
The innate and adaptive immunity form the pillars of the
human immune system and work on both the humoral and
cell-mediated level. Humoral immunity has been less extensively
studied in astronauts leading to rather inconsistent results [15,
16], while the impairment of cell-mediated immunity has been
confirmed during and after spaceflights [4]. NASA’s analysis of
cell-mediated immunity in the Twin Study, revealed that 50 of
the 62 studied cytokines were differentially abundant pre-, in-,
and post-flight, between the spaceflight and ground-based subject
[8]. Cytokines are produced by virtually all innate and adaptive
immune cells, but especially by T-helper (Th) lymphocytes. The
measurement of plasma cytokine concentrations in the mitogen-
stimulated blood of astronauts has been used to monitor immune
function and specific alterations in lymphocyte subpopulations
[17]. A cells inability to produce specific cytokines is indicative
of a potentially significant immune alteration that could reduce
immune defences during spaceflight [18]. Important for effective
cell-mediated immunity are the pro-inflammatory interleukin-2
(IL-2), interferon gamma (IFN-γ), and tumour necrosis factor
alpha (TNF-α) cytokines, and the anti-inflammatory cytokine
interleukin-10 (IL-10). However, these cytokines are not easily
classed since they could be capable of inducing both pro-and-
anti-inflammatory effects [19].
Mechanisms that produce immune system dysregulation
during spaceflight have not been clearly identified, mainly
due to the high costs of spaceflight experiments, the scarcity
of missions and experimental variations between flights
[20]. Terrestrial spaceflight analogues are a more accessible
alternative to study spaceflight-related health effects, their
causative factors and to test potential countermeasures [21].
For example, several ground-based studies could clearly
demonstrate the dramatic impact of microgravity on the
immune system [21–28]. However, during space travel, radiation
and psychological stress factors (e.g., isolation, sleep deprivation,
and heavy workload) may have a significant synergistic
or antagonistic effect on human immunity [29, 30]. Here,
terrestrial analogues offer not only financial and repeatability
advantages but also the opportunity to determine the relative
contribution of the individual space stressors to the observed
health effect by simulating them both individually and
in combination.
Space radiation has been recognized as a major health risk
for astronauts as current estimates suggest a round-trip to Mars
would result in >0.6 Sv or 60% of an astronaut’s career dose
[31, 32]. However, uncertainties on the existing biological data
limit the risk assessments for manned, deep space mission
[33]. To improve the current radiation risk estimation models,
a growing number of particle accelerator facilities configure
ground-based analogues for biology experiments [34, 35]. The
iThemba Laboratory for Accelerator Based Sciences (LABS) is
such a particle accelerator facility in South Africa, with a rather
unique, well-characterized quasi-monoenergetic neutron beam
line, covering an energy range from 30 up to 200 MeV for
metrology purposes, with great potential for space radiobiology
studies [36]. The space radiation environment is a complex
mixture of particles of galactic (galactic cosmic rays or GCR)
and solar (solar particle events or SPEs) origin, as well as their
secondaries (such as neutrons), that are produced by interactions
with the spacecraft materials and astronaut’s bodies. Secondary
neutrons may cover a complete energy range from thermal
neutrons (0.5–1 MeV) up to several GeV and are considered
to be highly carcinogenic and far more effective to induce
biological damage than low linear energy transfer (LET) radiation
[37–40]. Unique patterns of DNA damage, gene expression,
repair proteins mobilization, cytokine activation, and cellular
microenvironment remodelling are observed following exposure
to high-LET radiation.
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Particle accelerators are the only facilities where the health
risks of high energy neutrons (>20 MeV) can be studied
[41]. Therefore, limited information is currently available on
the impact of higher energy neutron irradiation on human
health, which has been identified as a particular concern for
civil aviation [42–44]. During long-term manned missions, both
the magnitude and duration of space radiation exposure will
increase, subjecting the flight crew to chronic, low doses and
low dose rates of secondary neutrons, for which there is limited
biological data pertaining to the immune impact. Recently, there
has been a growing interest to study the interaction between high-
LET radiation and human immunity, to explore the combined
use of particle therapy and immunotherapy in cancer treatments
[45, 46]. However, the exposure conditions in space and particle
therapy are quite different. During particle therapy, an acute,
high and localized radiation dose will be delivered to the tumour.
In contrast, the space radiation environment is characterised by
a chronic, low dose and dose rate of high-LET particles that
impact the astronauts whole body and could adversely affect their
immune system [10].
New insights and radiobiology data on high-LET radiation
effects at low dose rates will improve current risk projections
for space exploration and hopefully aid in the development and
evaluation of possible countermeasures [47]. With this goal,
the “Optimization and validation of a unique ground-based in
vitro model to study space health effects” (INVEST) project was
launched, which aims to implement a ground-based in vitro
model to study space health effects at iThemba LABS, with a
specific emphasis on neutrons at low doses and low dose rates.
The focus of this first pilot study was to optimize the in vitro
cytokine-release assay in collaboration with the project partner
SCK CEN, to investigate the impact of low dose rate neutrons on
cell-mediated immunity. For this pilot experiment, the clinical
fast neutron therapy beam line was used to irradiate whole blood
samples of healthy adult volunteers, at a lower dose rate (LDR) or
a higher (or normal clinical) dose rate (HDR).
Recall antigens and mitogens were used in this study to assess
the impact of neutron irradiation on the cytokine production
capacity of activated lymphocytes. A previous study observed
no increase in any adaptive immunity cytokines in astronauts
6 months aboard the ISS, suggesting that the astronauts were
simply free from infectious diseases while in flight [48]. A
potential alternative explanation for this observation is the
diminished T lymphocyte function and reduced activation in
astronauts due to the spaceflight, which will hinder their
cytokine response [49]. Here, the lymphocytes were intentionally
stimulated ex vivo to mimic a challenged immune scenario, to
monitor the disruptive effect of neutron dose and dose rate on the
cytokine release profile. This method has been extensively used
to study immune system dysregulation in several ex vivo studies
related to short and long duration spaceflights and in terrestrial
analogues [13, 29, 50, 51].
MATERIALS AND METHODS
Sample Collection
Ethical approval was obtained from the South African Human
Sciences Research Council (protocol number REC 3/23/10/19) in
accordance with the 1975 Declaration of Helsinki, as revised in
2000. Participants were recruited via an institution-wide email
addressed to iThemba LABS employees, in Cape Town, South
Africa. Written, informed consent was obtained from non-
smoking, non-medicating, male volunteers with no diagnosed
history of chronic illness (n = 8; age range: 22–63 years). Due
to the known variability in cytokine response between individual
subjects and the small sample size of this pilot study, the study
was restricted to male adult volunteers to limit the potential
influence of gender on the circulating cytokines levels in baseline
samples [52]. Peripheral blood samples were collected into
heparin-treated vacutainers (Becton Dickinson Company, New
Jersey, USA) and stored at room temperature before irradiation.
In vitro Irradiation
Whole blood samples were retained at room temperature for
∼24 h before being exposed to a clinical fast neutron beam
generated by bombarding 66 MeV protons on a Beryllium target
(p + 9Be→ n + 9B-1.85 MeV, plus several breakup reactions)
[53] in sterile 2.0mL cryogenic vials (NEST Biotechnology
Co., Ltd., Wuxi, China). A hydrogenous filter reduced the
contribution of thermal and epithermal neutrons. This results
in a neutron spectrum with a fluence-weighted average energy
of ∼29.8 MeV for the 290mm × 290mm field that was used
for the irradiations [53]. The source-to-phantom surface distance
was 1,500mm and irradiations were carried out at a gantry
angle of 270◦, resulting in a horizontal beam directed on the
water tank containing the blood samples at 37◦C. Two radiation
doses of 0.125 or 1Gy were administered at two different dose
rates: a lower dose rate (LDR) of 0.015 Gy/min and a higher
dose rate (HDR) of 0.400 Gy/min. Sham-irradiated samples were
retained in the control room, receiving only ambient radiation.
The output factor (1.097 Gy/Monitor Unit) was measured with
an Exradin T2 thimble ionization chamber placed at the same
position as the blood samples (at a depth of 52mm in the
water tank). The wall of this chamber is made from A-150
tissue-equivalent (TE) plastic and the 0.53 cm3 active chamber
volume was filled with a propane-based TE gas. Calibrations were
performed according to the neutron dosimetry protocol of the
ICRU Report 45 [54].
Whole Blood Immune Cell Stimulation
The in vitro cytokine release assay is a modified version of
the methods described by Feuerecker et al. [51] and Van
Walleghem et al. [22]. Post-exposure, irradiated whole blood was
distributed equally amongst culture tubes and diluted 1 to 1 in
750 µl Roswell Park Memorial Institute (RPMI) medium (Gibco,
Massachusetts, USA), supplemented with 10% foetal calf serum
(Lonza, Basel, Switzerland), 1% penicillin and streptomycin
(Lonza), with-or-without an immune cell stimulant, in sterile
2.0ml cryovials. Pokeweed mitogen (PWM) (Sigma-Aldrich,
Missouri, USA), heat-killed Listeria monocytogenes (HKLM)
(InvivoGen, Toulouse, France), or lipopolysaccharide (LPS)
(Sigma-Aldrich) were used as immune stimulants at final
concentrations of 0.5, 5, and 5µg/ml, respectively, as previously
optimized [21]. Unstimulated samples were included to provide
a baseline control condition for every stimulated sample and
to confirm that the stimulation achieved the desired effect.
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FIGURE 1 | Overview of experimental methodology. This schematic template illustrates the study process from blood sample collection, irradiation and stimulation, up
to Luminex analysis.
Post-irradiation and stimulation (or sham-irradiation and no
stimulation, in the case of controls), whole blood cultures were
maintained at 37◦C for 24 h and the plasma was separated by
1,500 g centrifugation for 15min before the supernatant was
transferred to cryovials and stored at −80◦C. The complete
experiment is outlined in Figure 1.
Luminex Measurement of Cytokine
Concentrations
For this pilot study, four key cell-mediated immunity cytokines,
IFN-γ, IL-10, IL-2, and TNF-α were quantified down to their
respective assay limits of 0.4, 1.6, 1.8, and 1.2 pg/ml. The R&D
systems (Minnesota, USA) Luminex assay was conducted exactly
to the manufacturer’s instructions as described elsewhere [29]
with two exceptions: only four cytokines were analysed here and
the Luminex assays were performed on a MAGPIX R© system
(Luminex Corp., Texas, USA). A further 1 to 1 dilution of
the plasma in assay diluent was performed to render analyte
concentrations within the assay’s linear range.
Data Analysis
Statistics
Statistical analysis was conducted using IBM SPSS Statistics 19
(New York, USA) while figures were plotted using GraphPad
Prism version 8.0 (California, USA). Cytokine data was presented
as grouped subject data with means and standard error of
the mean (SEM). In cases where the cytokine concentration
could not be confidently extrapolated from the standard curve,
the MAGPIX R© system reported an “out of range” value. In
these instances, the assay’s minimum detection limit value
was substituted for the “out of range” samples to enable
statistical analysis. To ensure normal distribution, data was
log10-transformed and verified by a Shapiro Wilk test (data not
shown). A repeated measures one-way ANOVA was used to
identify significant relationships between the unstimulated and
stimulated, irradiated and sham-irradiated samples as well as
the relationships between HDR and LDR irradiated samples. An
overall dose effect was determined using repeated measures one-
way ANOVA analysis on the pooled data of all irradiated samples
(0, 0.125, or 1Gy total dose) for each cytokine-stimulant pair.
This elucidates the effect of a specific dose on cytokine secretion
compared to the sham-irradiated control, disregarding the dose
rate. Similarly, the dose rate effect was determined using the same
analysis on the pooled dose rate results within each cytokine-
stimulant pair, regardless of the administered radiation dose.
Relationships were deemed significant when P < 0.05.
Effect Size Calculations
Due to the small sample size of this study and the resulting
low power to test statistical significance, effect size (ES) values
were calculated to determine the size by which the experimental
group varies from the control groups, expressed as the number
of standard deviations. A negative ES value specifies that the
experimental group mean is “x” amount of standard deviations
below the control mean, while a positive value indicates the
contrary. The ES assists in describing trends and relationships
between groups and is defined by the formula:
ES =
(experimental mean− control mean)
control standard deviation
In the present study, the ES was calculated to identify the effect
of various neutron doses in reference to the sham-irradiated
control. However, in order to determine the effect of neutron
dose rate, the lower, 0.015 Gy/min dose rate was compared to the
standard higher, 0.400 Gy/min dose rate, so the HDR group is
used as the “control” in the formula above.
RESULTS
Validation of the Cytokine Release Assay
Cytokines are soluble molecules which play a key role in
innate and adaptive immune responses. To validate the in
vitro cytokine release assay used for this pilot study, cytokine
titres in the unstimulated (baseline) samples were compared to
the stimulated samples. With a few exceptions, only minimal
detectable cytokine concentrations were observed at baseline
for all donors and the majority of the basal IL-2 and IFN-γ
cytokine levels were even below the detection limit for most
donors (Figure 2). Based on previous studies, it was expected
that the different stimuli would up-regulate plasma cytokine
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FIGURE 2 | Cytokine release assay validation—recall antigen and mitogen stimulation of whole blood samples. The graphs display the increase in log10-transformed,
cytokine titres between the unstimulated (Basal) and the recall antigen- or mitogen-stimulated (PWM, HKLM, or LPS) samples. The dots represent the measurements
of the individual participants and the horizontal lines denote means. The asterisks indicate various levels of significant difference (***P < 0.001 and *P < 0.05). (A) All
three stimuli significantly increased IFN-γ secretion. (B) All three stimuli result in a significant increase of IL-10 secretion compared to the basal level. (C) Only PWM
significantly increased IL-2 titres. (D) All three stimuli resulted in a significant increase in TNF-α levels.
FIGURE 3 | The log10-transformed mean cytokine concentrations. The above figures display the mean IFN-γ, IL-10, IL-2, and TNF-α titres in the stimulated (n = 8)
and unstimulated (n = 6), irradiated and sham-irradiated groups, with error bars indicating the SEM. When stimulated with PWM, 0.125Gy neutrons given at the
higher dose rate and 1Gy given at the lower dose rate, significantly increase IL-10 secretion (*P < 0.05) when compared to the sham-irradiated control (Graph E).
Graphs (A) to (D) and (F) to (P) display no significant relationships.
levels in whole blood cultures [55]. This was indeed observed
for three of the four measured cytokines (IFN-γ, IL-10, and
TNF-α), irrespective of the stimulant used for lymphocyte
activation (Figure 2). IL-2 concentrations deviated from this
trend. For some of the donors, the measured values were still
below the assay detection limit of 1.8 pg/ml after 24 h of
stimulation and out of the normal physiological range for healthy
adults (9.4–15.9 pg/ml) [56]. Minor, non-significant increases in
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IL-2 concentration were observed after 24-h stimulation with
HKLM or LPS for 50 and 25% of the donors, respectively.
PWM-stimulation on the contrary, induced a significant IL-2
increase for all donors compared to the basal levels (P < 0.001;
Figure 2C).
Impact of Neutron Dose and Dose Rate on
Cytokine Release
In most cases, neutron irradiation had no statistically significant
impact on cytokine secretion in stimulated and unstimulated
whole blood cultures, as depicted by the comparison of
group means in Figure 3. Under PWM-stimulation however,
exceptions to the norm were observed when the measured IL-10
concentration in the sham-irradiated cultures was compared
to the concentration in either the 1Gy LDR-treated group,
or the 0.125Gy HDR-treated group (P < 0.05; Figure 3E).
The lack of statistical significance under the other stimulant
or neutron treatment conditions might be attributable to the
low participant numbers, resulting in a lack of statistical
power to test the hypothesis. Nonetheless, some interesting
but non-significant trends were observed, that allude to
response patterns.
To independently monitor the effect of individual neutron
doses and dose rates on cell-mediated immunity parameters,
cytokine concentrations from various groups were pooled by
disregarding either the dose rate (for dose comparisons) or the
dose (for dose rate comparisons), within each stimulant and
cytokine group. Table 1 presents the observations from these
pooled comparisons. Again, a significant increase was observed
in IL-10 secretion in PWM-stimulated samples compared to the
stimulated control group concentration, for both the low and
higher neutron dose of 0.125 (P < 0.05) and 1Gy (P < 0.01).
Moreover, the pooled comparison between the LDR and HDR
highlights significantly suppressed IFN-γ secretion after HDR
exposure in all stimulated cultures (P < 0.01) and a significantly
suppressed IL-2 secretion in PWM-stimulated cultures (P< 0.05;
Table 1). A “native” response to HDR neutron treatment was
observed by a significant increase in TNF-α in unstimulated
cultures (P < 0.01; Table 1).
Effect Size
Effect size (ES) calculations were an eloquent solution to
highlight trends between normally distributed groups, in light of
the limited sample size and the large intra-participant cytokine
response variation (Table 2). To see the influence of the neutron
radiation dose and dose rate on in vitro cytokine secretion, the
data analysis strategy detailed in the Effect Size Calculations
section, was employed.
Dose Effect Size
“Dose ES” calculations revealed a downregulation of IL-2
secretion compared to the unirradiated samples for most stimuli
conditions, except for LPS, after both the 0.125 and 1Gy dose,
delivered at the HDR. This effect was most pronounced for
PWM-stimulated cultures and it is advisable to only focus on
the PWM results since IL-2 levels in LPS and HKLM stimulated
cultures were below the detection limit in most cases (Figure 2).
TABLE 1 | Summary of significant observations from pooled dose and dose rate
comparison.
Dose comparison
Cytokine Stimulant Agent Effect on
titre vs. Ctrl
P-Value
IL-10 PWM 0.125Gy total
dose
Increase <0.05










IL-2 PWM HDR Decrease <0.05
TNF-α None HDR Increase <0.01
The term “Agent” refers to the factor identified as having the significant impact on the
measured plasma cytokine titre. The “Effect on titre” present the trend in relation to the
sham-irradiated control (in the case of dose comparison) and in relation to the alternative
dose rate (in the dose rate comparison). The dose rate comparisons presented here
indicate that, IFN-γ and IL-2 secretion in stimulated cultures were significantly lower in
HDR-treated cultures, when compared to LDR-treated cultures.
There was a general increase in IL-10 concentration in all
irradiated conditions compared to the unirradiated samples,
regardless of the stimulant used. However, the LDR minimally
suppressed IL-10 secretion in the unchallenged immune system
at 0.125Gy (Figure 3H).
Considering the IFN-γ ES data, the HDR seemed to have
a more pronounced impact on the cytokine secretion levels
at both 0.125 and 1Gy, regardless of the stimulant employed
(Table 2). The LDR-treated samples typically showed higher,
slight increases in IFN-γ plasma levels at 0.125 and 1Gy.
Unfortunately, no ES could be identified for unstimulated (basal)
samples since IFN-γ baseline values were below the detectable
limit of the assay. Neutron treatment had minimal impact on
the TNF-α concentrations except in the unstimulated groups
where the 0.125Gy LDR marginally reduced TNF-α secretion in
comparison to the same HDR dose point.
Dose Rate Effect
While Tables 1, 2 mainly focus on the statistical significance
of the observed effects and the size of the shifts in cytokine
levels between the LDR and HDR, it is advisable to consult
(Figure 3) which illustrates the potential decrease or increase
of the observed trend. The “Dose rate ES” analysis indicates
consistently higher IL-2 and IL-10 levels at the 1Gy neutron
dose in the LDR treatment arm compared to HDR arm for
all stimuli. For IL-2, the combination of the LDR-0.125Gy and
PWM-stimulation resulted in higher cytokine levels compared
to the HDR-0.125Gy condition, while the opposite effect on
IL-10 levels. The most reliable IL-2 conclusions can be drawn
on the PWM stimulation, which suggest a dose rate effect,
whereas the effects on IL-10 levels seem to be dose-specific
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TABLE 2 | Effect size.
Dose ES Dose rate ES
LDR vs. 0 Gy HDR vs. 0 Gy LDR vs. HDR
Dose 0.125 Gy 1 Gy 0.125 Gy 1 Gy 0.125 Gy 1 Gy
IL
-2
Basal Undef Undef Undef Undef Undef Undef
PWM 0.029 0.027 −1.218 −0.964 0.667 0.613
HKLM −0.707 0.095 −0.554 −0.376 −0.214 0.503




Basal −0.432 −0.052 0.169 0.098 −0.541 −0.280
PWM 0.250 1.144 0.861 0.463 −0.511 0.578
HKLM 0.281 0.683 0.339 0.397 −0.080 0.296




Basal Undef Undef Undef Undef Undef Undef
PWM 0.211 0.077 −0.701 −0.945 0.501 0.486
HKLM 0.259 0.097 −0.945 −0.530 1.014 0.698





Basal −0.472 −0.114 0.136 0.104 −0.575 −0.248
PWM −0.158 0.147 0.103 0.025 −0.252 0.127
HKLM −0.193 −0.022 −0.062 −0.031 −0.115 0.009
LPS −0.131 0.159 −0.218 −0.051 0.075 0.186
Effect sizes (ES) were calculated based on the log10-transformed cytokine concentrations the basal (n = 6) or stimulated (n = 8) samples exposed to neutron doses of 0, 0.125, and
1Gy at either LDR 0.015 Gy/min or HDR 0.400 Gy/min dose rate. The “Dose ES” column illustrates the number of standard deviations by which the irradiated group mean deviates from
the sham-irradiated group mean. The “Dose rate ES” column compares the effect of the LDR on cytokine secretion, using the HDR as the control group across two doses, 0.125 and
1Gy. Red-shaded cells indicate an increase, while blue-shaded cells indicate the converse. The intensity of the cell’s colour represents the magnitude of the effect, while the red-shaded
cells indicate higher levels and blue-shaded cells the converse. “Undef” denotes instances where the standard deviation in the control group was zero, because basal cytokine levels
were below the assay detection limit. This lack of standard deviation prevented effect size calculations. It is important to remember that the dose rate ES values reflect the number of
standard deviations by which the LDR-group mean differs from the HDR-group mean. For example, the dose rate ES calculation for the IL-2 concentration in PWM-stimulated cultures
indicates that, at the 1Gy dose points (top right corner), the LDR cultures had higher IL-2 concentration than its HDR counterpart. This is also indicated by the red shade of this cell.
Although, this does not indicate the relationship relative to the control population (that can be seen in Figure 3). In this respect, the Dose rate ES table is better understood when read
in conjunction with Figure 3.
with no conclusive dose rate effect. ES calculations confirmed
the pooled statistical analysis of IFN-γ measurements as there
was a clear trend in dose rate effect (Table 2), where the HDR
exposures gave rise to a decrease in IFN-γ secretion for the three
different stimuli at both neutron doses (Figures 3A–C) when
compared to the LDR treatment group and the unirradiated
control samples. Considering TNF-α dose rate ES data, the LDR
seems to reduce cytokine secretion in the unchallenged immune
system but the dose rate had marginal impact on the cytokine
levels in stimulated cultures.
DISCUSSION
Although it is well-known that dysregulation of the immune
function occurs and persists during spaceflight, the exact nature
of the immunological changes and their specific cause has not
yet been fully elucidated. Therefore, the present study used the in
vitro cytokine release assay to monitor alterations in the plasma
levels of pro- (IFN-γ, IL-2, and TNF-α) and anti-inflammatory
(IL-10) cytokines induced by low (0.125Gy) or high (1Gy)
neutron doses administered at two different dose rates (0.400
or 0.015 Gy/min). The cytokine response of the immune cells
was measured after 24 h of stimulation with mitogens or recall
antigens. To the best of our knowledge, this is the first study
measuring the effect of neutron irradiation and potential dose
rate effects on the cytokine release capacity of immune cells, to
address the knowledge gap on chronic exposure to neutrons in
light of the anticipated interplanetary travel and exploration of
the Martian surface [57–59]. In general, this pilot study did not
reveal statistically significant changes in cytokine release after
neutron irradiation. However, some first trends after neutron
exposure were observed depending on the cytokine and the
stimuli used.
During the in vitro cytokine release assay, whole blood
samples were supplemented with recall antigens or mitogens
(PWM, HKLM, and LPS). The addition of the stimuli resulted
in an expected upregulation of plasma cytokine levels (Figure 2)
in line with previous observations, confirming the efficacy of
the assay [55]. Basal IL-2 and IFN-γ concentrations were below
the assay detection limit, indicating that the study population
was indeed healthy and there was no sign of infection [56]. In
a previous study, IL-2 secretion was only increased for 50% of
the subjects after exposure to LPS [22]. We observed an increase
for only 25% of the donors after LPS stimulation. Moreover,
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the only statistically significant increase in IL-2 concentration
was observed after PWM stimulation. IL-2 acts by priming
CD8+ T cells to eliminate virus-infected cells. The low IL-2
secretion following stimulation with HKLM and LPS are possibly
due to these mitogens mimicking a bacterial, rather than a
viral challenge.
At the unstimulated baseline, TNF-α concentrations were
within the expected normal physiological range with one
participant showing a titre roughly 50% higher than the other
study participants. Studies conducted to investigate cytokine
levels in healthy subjects have established differing “normal”
baseline cytokine profiles based on the characteristics of their
study populations and the method of cytokine measurement
[19, 60]. Based on the great variation in baseline cytokine levels
amongst donors and the limited availability of comparative study
data, it was decided that none of the donors could be excluded
from the statistical analysis in this study based on a literature
comparison alone. In addition, a large intra-individual variation
was also observed in the exposed samples which is reflected by
the relatively broad error bars in Figure 3. While no conclusive
results could be obtained in the present study, it might be
valuable to investigate cytokines responses at individual level
after irradiation exposure in future studies.
Evidence suggests that IL-2 stimulation during the primary
immune response is critical for secretion of CD8+T lymphocytes
to combat viral infections [61]. During an infection, a co-
ordinated action by pro-inflammatory cytokines must guarantee
the clearing of the invading pathogen. Once this is achieved, they
are downregulated by anti-inflammatory cytokines such as IL-10,
before tissue damage or pathology occurs. A timely and dynamic
balance exists between pro- and anti-inflammatory cytokines to
ensure an infection is resolved [62]. In this study, only the effects
of neutron irradiation on the PWM-induced IL-2 secretion
can be taken in consideration, since all the other stimulation
conditions produced IL-2 concentrations that were below the
assay detection limit (Figure 2). A non-statistically significant
trend was observed for the dose rate in the PWM-stimulated
group, where the HDR suppressed IL-2 secretion compared
to LDR exposure for both 0.125 and 1Gy (Figure 3I). In a
challenged immune system, a potential neutron-induced IL-2
suppression could give rise to reduced primary and secondary
antigen-specific CD8+ expansion and an inefficient immune
response [63].
IL-10 is described as a pleiotropic cytokine, since it acts in
both innate and adaptive immunity as an anti-inflammatory
molecule [64] and is involved in the prevention and limitation
of immune reactions [65]. A significant increase was observed in
IL-10 secretion under PWM-stimulation and neutron treatment
at LDR 1Gy and HDR 0.125Gy (Figure 3E). IL-10 was
the only anti-inflammatory cytokine included in this study
and the only cytokine that showed a consistent, but not
statistically significant upregulation after neutron irradiation
and stimulation (Table 2—left side). These results indicate that
neutron irradiation could induce anti-inflammatory activity,
independent of the dose rate.
Previous research conducted on rats flown on the US
Space Shuttle revealed that the animals had suppressed IFN-γ
levels which could be associated with a heightened risk to
viral infections [66]. IFN-γ plays an essential role in the
innate and adaptive immune response against pathogens and
tumour development but unregulated IFN-γ secretion can
cause pathological inflammatory conditions [67]. The grouped
dose rate analysis highlighted an inverse relationship between
IFN-γ levels and dose rate, suggesting that the LDR may
facilitate a competent immune response to viral challenge,
while the HDR resulted in a non-statistically significant
downregulation after stimulation. This trend, which can be
observed in Figures 3A–C, and was confirmed by the effect
size calculations that showed a suppression of the IFN-γ
secretion after HDR irradiation in response to stimulation
(Table 2—left side).
TNF-α is an important factor for T lymphocyte signalling and
activation to induce an appropriate response from initiation to
pathogen elimination and has a well-defined role in the defence
against several bacterial pathogens [68, 69]. In this study, TNF-α
is the only cytokine for which no real trends could be observed
in the stimulated, irradiated whole blood cultures. However,
the upregulation of IL-10 secretion might have antagonised the
TNF-α levels in the stimulated cultures. An interesting yet not
statistically significant response was observed in the unstimulated
group, where LDR neutrons downregulated the TNF-α secretion
after 0.125Gy compared to the HDR (Figure 3P). This suggests
that, even before mitogen stimulation, a dose rate-dependent
response is visible and LDR neutron radiation might induce a
suppressed ability to mount an effective immune response.
Significant reductions in mitogen-stimulated production
of different cytokines was observed in peripheral blood
mononuclear cells isolated from whole blood samples, that were
collected during long-duration spaceflight [7]. The inability of
the dysregulated immune system to respond and clear infections
or pre-cancerous cells is concerning in light of the confined
living condition and radiation-rich environment that astronauts
will inhabit during interplanetary trips. While most of the
observed immune alterations up to now have been linked and
attributed to microgravity conditions in ground-based set-up,
some components of the immune system are among the most
radiosensitive tissues in the body. Unfortunately, results on
the effect of cosmic radiation on the immune system remain
limited [10, 20]. Most evidence for the effects of space radiation
exposures in humans has been derived from epidemiological
studies on the atomic-bomb survivors, radiotherapy patients,
and occupationally exposed workers. While these studies provide
valuable insights, our knowledge on the true risks from low
dose rate exposure to high-LET radiation relevant to space
is limited and remains one of the main challenges to predict
space radiation health risks for exploration astronauts [70].
Currently, NASA’smost advanced GCR simulators provides some
insight into the effect of GCR on biological systems [70]. A
recent study by Moreno-Villanueva and colleagues examined the
combined and individual effects of γ-radiation (radiation source
undefined), simulated microgravity and physiological stress on
isolated, unstimulated, peripheral blood mononuclear cells [29].
They concluded that radiation significantly influenced cytokine
secretion but only under simulated microgravity conditions.
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In addition, pre-exposure to simulated psychological stress
mitigated the effects of microgravity. These important findings
suggest possible synergistic effects that may offer some level of
protective compensation during spaceflight. Since no additional
space stressors were used in the current pilot study, this
could also be one of the reasons why almost no significant
effects on cytokine secretion could be observed with neutron
irradiation alone.
When astronauts go beyond LEO, they are exposed to high
doses of space radiation, consisting of protons and heavy charged
nuclei, as well as secondary neutrons of a wide spectrum of
energies produced by interaction of the charge particles with
the human body, spacecraft and other material surroundings
[71]. Most existing studies on neutron radiation focus on their
carcinogenic risks and are primarily based on experiments with
exposures to neutron energies below 20 MeV, while simulation
and dosimetry studies illustrate that neutron energies in space
environment go up to much higher energies [58]. In addition,
measurements on the Martian surface show that neutrons will
be a significant contributor to measured absorbed dose and it is
estimated that they contribute ∼15% toward the intravehicular
dose to astronauts [57, 58, 72]. Though the immune impact of
neutron irradiation is poorly studied, a gene expression study
by Broustas et al. illustrated a clear suppression of immune cell
function after 1Gy neutron irradiation and downregulation of
genes that were related to the immune system response and B
and T cell physiology [73].
This pilot study has several limitations, where the small
study population presented one of the main constraints to
draw statistically significant conclusions. However, it is a first
illustration of the size of variation, which can form the basis for
appropriate sample sizes calculation and to test the feasibility of
future experiments [74, 75]. The LDR in the current study is still
much higher than the expected intravehicular dose rate during
cosmic travel, which is estimated be 0.3–0.6 mGy per day or 2.08
× 10−4 to 4.17 × 10−4 mGy/min [58]. The measured dose rate
for the Martian neutron spectrum ranges from 8 to 740 MeV
was 0.014 ± 0.004 mGy/day [57, 59]. We were unfortunately
limited to a dose rate of 0.015 Gy/min due to the detection limits
of the electronics of the clinical neutron therapy beam line that
was used in this study. However, this 25-time reduction in dose
rate compared to the HDR of 0.400 Gy/min, was considered to
be sufficient for this proof-of-principle study. Moreover, we were
able to demonstrate a neutron dose rate effect on DNA double
strand break induction as early as 30min after irradiation with
the same irradiation set-up [50]. It should also be noted that an
absorbed neutron dose of 1Gy as used in this pilot study is not
trivial and is possibly much higher than the expected absorbed
neutron doses for astronauts on a Mars mission. However,
since this was a pilot study, it was decided to include a low
(0.125Gy) and high (1Gy) neutron dose in order to evaluate
the effect of the dose in this first step of the project. Neutron
exposures of this magnitude are expected to induce apoptosis in
a substantial proportion of the lymphocyte population and the
lack of viability or apoptosis data can be seen as a limitation in
this study.
Despite the limited number of study participants, the results
demonstrate some first trends in certain cytokine secretions after
irradiation with fast neutrons, where dose rate only seems to
have an impact on the IFN-γ and IL-2 secretion after specific
stimulation. However, the majority of these observations were
not statistically significant. Another important limitation of this
pilot study is the use of whole blood samples and not highly
purified subpopulations. Therefore, this method does not provide
the ability to identify the specific population of cells responsible
for the observed increase or decrease in cytokine secretion. The
use of whole blood may also be advantageous because it can
display differences in cytokine secretion due to complex cell–cell
interactions and the plasma, thereby better reflecting the in vivo
environment. Notwithstanding these limitations and with great
caution taken to not generalise the effects from a finite sample
population, we can conclude that there is future scope for these
types of experiments.
An important objective for future experiments is to take the
additional layers of spaceflight complexity into consideration by
mimicking the synergistic effect of multiple space stressors in
a ground-based experiment, as outlined by Moreno-Villanueva
et al. [29]. In addition, the future goal should also include in
vivo experiments with neutrons and other high-LET radiation
qualities relevant to the space radiation environment, with special
emphasis for spaceflight-relevant low dose rates. Moreover,
future studies should include cell viability and cell cycle
assessments in order to take into consideration the starting
concentration of cells in each sample, which can have a significant
effect on the cytokine measurements. Unfortunately, lower dose
rates remain technically challenging to administer to biological
samples and beam time limitations at accelerator facilities
might hinder the administration of the ultra-low dose rates
observed in space. In spite of these limitations, the INVEST
collaboration endeavours to further ground-based space research
in Africa and to examine the individual and combined effects
of spaceflight stressors (radiation, physiological stress, and
microgravity) on the human immune system. Given the intended
future of human spaceflight and the rapid expansion of the
capabilities for human missions to the moon and Mars, there
is a pressing need to improve the understanding of the space
radiation risk, predict likely clinical outcomes of interplanetary
radiation exposure, and develop appropriate and effective
mitigation strategies for future missions [70]. The current study
on low dose and dose rate neutron irradiation presents a
first small step toward the giant leap still needed to achieve
this goal.
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